Some patient groups, including the American Cancer Society Cancer Action Network and the American Lung Association opposed the bill because they said it could do more harm than good.
The Pennsylvania-based health care chain Geisinger Health System plans to soon offer DNA sequencing as part of routine care for all patients. Is there a downside?
Don Gonyea talks to Kaiser Health News' Julie Rovner about the Trump administration's decision to revive a rule that cuts off federal family planning money from organizations that provide abortions.
The latest installment in our Bill of the Month series about a huge bill for four orthopedic screws drew lots of responses from readers and listeners. Some had ideas for improving the health system.
The Trump administration is pulling out an old regulation that it believes will be able to meet a conservative goal: cutting a key program's funding for Planned Parenthood. The strategy might work.
An antibody-based drug reduces the frequency of migraine headaches, according to data reviewed by the Food and Drug Administration. The agency approved Aimovig, priced at about $6,900 a year.
City supervisors tried to ban menthol cigarettes and vape flavors in 2017, but tobacco purveyors funded a drive to put the measure to voters instead. Now dueling ads vie for hearts and minds.
An aggressive type of breast cancer — a HER2-positive tumor — often shrinks with Herceptin treatment, but side effects can be tough. Researchers say a shorter course of the drug may be a good option.
The number of children and teens who visited the hospital for suicidal thoughts or attempts doubled from 2008 to 2015. Rates were highest during the school year.